Dear Women's Imaging Insider,
What if there were biomarkers that could signal breast cancer's aggressiveness -- particularly triple-negative breast cancer? A study conducted by researchers from the University of California, San Francisco suggests that there just might be.
Dr. Marjan Bolouri and colleagues found that a strong correlation between dynamic contrast-enhanced MRI signal enhancement ratio and maximum standardized uptake values from PET/CT illuminates the progression of triple-negative breast cancer, as well as a patient's prognosis. Click here to read more in an article by AuntMinnie.com features editor Wayne Forrest.
After you're finished with our Insider Exclusive -- available to you before the rest of our AuntMinnie.com members -- find out what else is going on in the Women's Imaging Digital Community:
- Discover what Italian researchers have to say about tailored breast cancer screening programs.
- Get the scoop on breast tomosynthesis and recall rates.
- Learn why mammography recall rates vary, depending on practice site.
As always, if you have a comment, report, or article idea to share about any aspect of women's imaging, I invite you to contact me.
